newsfilter
← Latest News
GlobeNewswire·

Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction

SenlangBio, a world-class cell therapy company, has developed a robust pipeline which includes 15 autologous and universal ("off-the-shelf") CAR-T and CAR-γδT cell therapy candidates targeting hematologic malignancies and solid tumors SenlangBio's l